Product Overview
Ponatinib HCl | T2372L | TargetMol Chemicals
CAS: 1114544-31-8
Smiles: Cl.CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4cccnn34)cc2C(F)(F)F)CC1
Formula: C29H28ClF3N6O
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: Ponatinib is an oral drug for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. It is a multi-targeted tyrosine kinase inhibitor. Ponatinib has been designed to be effective against these types of tumors.
Molecular Weight: 569, 03
